Evidence map›Paper›PMID 29652087›Full record

ArticleClinical genetics2018

Expanding the clinical spectrum of biallelic ZNF335 variants.

K Stouffs, A B Stergachis, T Vanderhasselt, A Dica, S Janssens, L Vandervore, A Gheldof, O Bodamer, K Keymolen, S Seneca and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Autosomal Recessive Primary Microcephaly: Not Just a Small Brain.Frontiers in cell and developmental biology · 2021
    Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

K StouffsCenter for Medical Genetics, UZ Brussel, Brussels, Belgium.
A B StergachisDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
T VanderhasseltDepartment of Radiology, UZ Brussel, Brussels, Belgium.
A DicaPediatric Neurology Clinic, Alexandru Obregia Hospital, Bucharest, Romania.
S JanssensCentre for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
L VandervoreNeurogenetics Research Unit, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
A GheldofCenter for Medical Genetics, UZ Brussel, Brussels, Belgium.
O BodamerDivision of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
K KeymolenCenter for Medical Genetics, UZ Brussel, Brussels, Belgium.
S SenecaCenter for Medical Genetics, UZ Brussel, Brussels, Belgium.
I LiebaersCenter for Medical Genetics, UZ Brussel, Brussels, Belgium.
D JayaramanDivision of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
H E HillDivision of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
J N PartlowDivision of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
C A WalshDivision of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
A C JansenNeurogenetics Research Unit, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0002-3835-2824
Vrije Universiteit Brussel · BEBoston Children's Hospital · USUniversitair Ziekenhuis Brussel · BEBrigham and Women's Hospital · USGhent University Hospital · BESpitalul Clinic de Psihiatrie Alexandru Obregia · RO

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
HUMAN EPILEPSY GENETICS--NEURONAL MIGRATION DISORDERSR01NS035129 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · 1997 to 2023
$9.5M
Howard Hughes Medical InstituteNIGMS NIH HHS T32 GM007753NINDS NIH HHS R01 NS035129
6 · The paper itself

Abstract

ZNF335 plays an essential role in neurogenesis and biallelic variants in ZNF335 have been identified as the cause of severe primary autosomal recessive microcephaly in 2 unrelated families. We describe, herein, 2 additional affected individuals with biallelic ZNF335 variants, 1 individual with a homozygous c.1399 T > C, p.(Cys467Arg) variant, and a second individual with compound heterozygous c.2171_2173delTCT, p.(Phe724del) and c.3998A > G, p.(Glu1333Gly) variants with the latter variant predicted to affect splicing. Whereas the first case presented with early death and a severe phenotype characterized by anterior agyria with prominent extra-axial spaces, absent basal ganglia, and hypoplasia of the brainstem and cerebellum, the second case had a milder clinical presentation with hypomyelination and otherwise preserved brain structures on MRI. Our findings expand the clinical spectrum of ZNF335-associated microcephaly.

Indexed as

AllelesAlternative SplicingBasal GangliaBrainDNA-Binding ProteinsFemaleHomozygoteHumansInfantInfant, NewbornIntracellular Signaling Peptides and ProteinsMaleMicrocephalyMutationNerve DegenerationNeurogenesisDNA-Binding ProteinsIntracellular Signaling Peptides and ProteinsNuclear ProteinsTranscription FactorsZNF335 protein, humanbasal gangliamicrocephalyneurodegenerationneurogenesisZNF335

Identifiers

PMID29652087
PMCPMC6361164
OpenAlexW2797456462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.